Cancer
Our cancer research examines many of the most prevalent cancers today with the goal of finding new and innovative therapies, treatments and ultimately prevention and cures.
Our researchers discovered a link between finasteride, a medication used to relieve urinary problems, and prevention of prostate cancer.
The Mays Cancer Center is a member of The Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC).
Clinical trial participation is an invaluable way to contribute to the pursuit of new treatments for cancer. Take action today...volunteer and play a role in finding a cure.
Find
Home to the only National Cancer Institute-designated cancer center in South Texas, UT Health San Antonio MD Anderson Cancer Center conducts more than 200 clinical trials in over 30 types of cancers.
Additional Highlights
-
Risk of death twice as high among cancer patients with COVID-19
Cancer patients who get COVID-19 have a 13% risk of dying, more than double the rate for all patients with COVID-19 combined.
Read the full story in the Newsroom -
Voelcker Fund awards $650,000 to cancer researchers on the rise
The Max and Minnie Tomerlin Voelcker Fund is awarding $650,000 to UT Health San Antonio to support innovative cancer research projects conducted by rising star faculty members.
Read the article at UT Health San Antonio's Newsroom -
Cancer drugs cause large cells that resist treatments; scientist aims to stop it
Daruka Mahadevan, MD, Ph.D., professor and chief of the Division of Hematology-Oncology in the Long School of Medicine, has studied this progression for 20 years. In a paper published in April 2020 in the journal Trends in Cancer, he and co-author Gregory C. Rogers, Ph.D., explain a rationale for stopping it.
Learn more at UT Health San Antonio's Newsroom -
A COVID-19 update from the director of the Mays Cancer Center
Ruben Mesa, M.D., FACP, director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson, shares an update on how the Mays Cancer Center is continuing to care for patients using innovative safety precautions during the coronavirus (COVID-19) pandemic. For more information, call the Mays Cancer Center at 210-450-1000.
Watch the video update in the Newsroom